BPA Call 36C24123A0032-36C24126N0219
- Veracyte Labs SD Corporation (operating as the Decipher Biosciences, Inc. Division) has been awarded a $307,856.05 firm fixed-price blanket purchase agreement call for prostate testing services by Veterans Integrated Service Network 1, a civilian agency within the Department of Veterans Affairs. The work will be performed in San Diego, California, with an ultimate completion date of January 31, 2026. This contract award increases funding to purchase order 523C58151 and is executed under the...
- Veracyte Labs SD Corporation, operating under its Decipher Biosciences division, was awarded a Blanket Purchase Agreement call valued at $194,435.40 by Veterans Integrated Service Network 8 on February 1, 2026, with performance completion by January 31, 2027. This firm fixed-price contract, which carries no set-aside designation, establishes a cost-per-test pricing structure for Decipher Prostate Cancer genomic testing services to be performed in San Diego, California. The contract operates...
- This federal contract award, valued at $61,571.21, was issued by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for the Decipher Prostate Cancer Testing service, which analyzes tumor gene expression patterns to help clinicians make more informed treatment...
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a $324,059 delivery order by Veterans Integrated Service Network 2 on October 23, 2025, for the provision of Decipher Prostate Cancer testing services at the Northport Veterans Affairs Medical Center. The contract, which is not set aside for any specific business category, is structured as a firm fixed-price delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule...
- Veracyte Labs SD Corporation, operating under its Decipher Biosciences, Inc. division, received a $22,684.13 firm fixed-price blanket purchase agreement call from Veterans Integrated Service Network 17 (VISN 17) on November 15, 2024, for the modification of Decipher Prostate Cancer testing services. The contract is scheduled for completion by November 14, 2025, with performance taking place in San Antonio, Texas. This award represents a task order issued under an existing $991,815.95 blanket...
- This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification of the Decipher Prostate Cancer Testing service. The $64,811.80 contract has an ultimate completion date of November 14, 2026 and is not set aside. Veracyte, a for-profit medical diagnostics company, provides specialized genomic testing services to support precision medicine and personalized...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...
- This federal contract award is for TESTING SERVICES- LAB provided by Veracyte Labs SD Corporation, a subsidiary of Veracyte, Inc. The contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) and does not have a set-aside designation. The contract, valued at $272,209.56, is a Delivery Order under Veracyte's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). Through this award, Veracyte...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for the provision of Veracyte's proprietary Decipher Prostate Cancer Testing, Packaging, and Transport services to the VA San Francisco healthcare facility. The contract has a ceiling value of $648,118.00 and a period of performance through...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- 36F79721D0019-36C24123A0032Blanket Purchase Agreement
- 36C24123A0032-36C24126N0219BPA Call
Veracyte Labs SD Corporation (a division of Decipher Biosciences, Inc.) received a Blanket Purchase Agreement call valued at $281,000 from Veterans Integrated Service Network 1, a civilian agency within the Department of Veterans Affairs, for prostate testing services. The contract is firm fixed-price with an ultimate completion date of January 31, 2027, and will be performed in San Diego, California. This delivery order is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and represents a call against an existing master BPA. The award carries no set-aside designation, reflecting the specialized and proprietary nature of Veracyte's genomic diagnostic capabilities. The primary service being delivered is the Decipher Prostate Cancer Test, a genomic classifier that analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential to support precision medicine initiatives across the VA healthcare system. Veracyte Labs SD Corporation has established itself as a key federal contractor for genomic testing services, holding multiple BPAs and indefinite delivery contracts across numerous Veterans Integrated Service Networks and the Defense Health Agency. The parent company, Veracyte, Inc., maintains an extensive federal contract portfolio totaling millions of dollars, positioning the organization as a leading provider of advanced molecular diagnostic services to federal healthcare agencies serving veterans and military beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/19/26 |